BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goddard CJ, Smith A, Hoyland JA, Baird P, McMahon RF, Freemont AJ, Shomaf M, Haboubi NY, Warnes TW. Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis. Gut. 1998;43:433-440. [PMID: 9863492 DOI: 10.1136/gut.43.3.433] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Zachariae H, Heickendorff L, Søgaard H. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up. Br J Dermatol 2001;144:100-3. [PMID: 11167689 DOI: 10.1046/j.1365-2133.2001.03959.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
2 Ciftciler R, Ozenirler S, Yucel AA, Cengiz M, Erkan G, Buyukdemirci E, Sönmez C, Esendaglı GY. The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2017;31. [PMID: 27925300 DOI: 10.1002/jcla.22109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
3 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1626] [Article Influence: 129.4] [Reference Citation Analysis]
4 Warnes T, Roberts S, Smith A, Haboubi N, McMahon RF. Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key? J Clin Pathol 2019;72:669-76. [PMID: 31371396 DOI: 10.1136/jclinpath-2019-205958] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33-60. [PMID: 16139830 DOI: 10.1016/j.cca.2005.06.014] [Cited by in Crossref: 223] [Cited by in F6Publishing: 232] [Article Influence: 13.9] [Reference Citation Analysis]
6 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151-166. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 43] [Article Influence: 31.0] [Reference Citation Analysis]
7 Wang JY, Zhang QS, Guo JS, Hu MY. Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol 2001; 7(1): 115-119 [PMID: 11819745 DOI: 10.3748/wjg.v7.i1.115] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
8 Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol. 2013;50:1007-1015. [PMID: 23558974 DOI: 10.1177/0300985813485099] [Cited by in Crossref: 283] [Cited by in F6Publishing: 266] [Article Influence: 35.4] [Reference Citation Analysis]
9 Yokohama S, Tokusashi Y, Nakamura K, Tamaki Y, Okamoto S, Okada M, Aso K, Hasegawa T, Aoshima M, Miyokawa N, Haneda M, Yoneda M. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World J Gastroenterol 2006; 12(2): 322-326 [PMID: 16482638 DOI: 10.3748/wjg.v12.i2.322] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
10 Levy M, Mccaughan G, Marinos G, Gorrell M. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection: Fibroblast activation protein expression and liver fibrosis. Liver 2002;22:93-101. [DOI: 10.1034/j.1600-0676.2002.01503.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
11 Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, Kim IH, Ma HY, Kisseleva T. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 2014;5:167. [PMID: 25100997 DOI: 10.3389/fphar.2014.00167] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
12 Gorrell MD, Wang XM, Levy MT, Kable E, Marinos G, Cox G, Mccaughan GW. Intrahepatic Expression of Collagen and Fibroblast Activation Protein (FAP) in Hepatitis C Virus Infection. In: Back N, Cohen IR, Kritchevsky D, Lajtha A, Paoletti R, editors. Dipeptidyl Aminopeptidases in Health and Disease. Boston: Kluwer Academic Publishers; 2004. pp. 235-43. [DOI: 10.1007/0-306-47920-6_28] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
13 Dai K, Qi JY, Tian DY. Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice. World J Gastroenterol 2005; 11(31): 4822-4826 [PMID: 16097051 DOI: 10.3748/wjg.v11.i31.4822] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]